drug · small molecule
OPC-1
Phase 2updated 3mo agoby $LCTX Lineage Cell Therapeutics, Inc.🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 7- tagApproval114 co-mentions · 40 sources
- drugaripiprazole LA34 co-mentions · 17 sources
- drugABILIFY MAINTENA KIT34 co-mentions · 17 sources
- tagSmall Molecule23 co-mentions · 23 sources
- companyAscend Laboratories Ltd2 co-mentions · 1 sources
- companyAurobindo Pharma Ltd1 co-mentions · 1 sources
- tagRecall1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 12 approved and 22 investigational indications.
targets
5-hydroxytryptamine receptor 2AD(2) dopamine receptor5-hydroxytryptamine receptor 1A
all catalysts(0)
nothing on the calendar yet
Trials studying OPC-1
- phase2Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- phase1A Study to Test the Effects of Itraconazole and Carbamazepine on OPC-167832 in Healthy Men and Women
- phase2A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure
- phase1A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men
- phase3OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
- phase2Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
- phase2A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
News(1)
- As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the doorDespite the recent emergence of a new drug class, schizophrenia remains one of the most challenging neuropsychiatric diseases to treat—and Cobenfy's first steps into the market indicate there is st…biospace · 10d ago
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that